214 related articles for article (PubMed ID: 29122300)
1. Using prognostic models in CLL to personalize approach to clinical care: Are we there yet?
Mina A; Sandoval Sus J; Sleiman E; Pinilla-Ibarz J; Awan FT; Kharfan-Dabaja MA
Blood Rev; 2018 Mar; 32(2):159-166. PubMed ID: 29122300
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors and risk stratification in chronic lymphocytic leukemia.
Parikh SA; Shanafelt TD
Semin Oncol; 2016 Apr; 43(2):233-40. PubMed ID: 27040701
[TBL] [Abstract][Full Text] [Related]
3. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
International CLL-IPI working group
Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
[TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in chronic lymphocytic leukemia: Clinical applications and prognostic markers.
Amaya-Chanaga CI; Rassenti LZ
Best Pract Res Clin Haematol; 2016 Mar; 29(1):79-89. PubMed ID: 27742074
[TBL] [Abstract][Full Text] [Related]
6. Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.
Li H; Yi SH; Xiong WJ; Liu HM; Lyu R; Wang TY; Liu W; Zhong SZ; Yu Z; Zou DH; Xu Y; An G; Li ZJ; Qiu LG
Chin Med J (Engl); 2017 Jan; 130(2):135-142. PubMed ID: 28091403
[TBL] [Abstract][Full Text] [Related]
7. [News in therapeutic management of chronic lymphoid leukemia].
Michallet AS; Salles G; Coiffier B; Michallet M
Bull Cancer; 2005 Mar; 92(3):249-56. PubMed ID: 15820919
[TBL] [Abstract][Full Text] [Related]
8. Prognostication of chronic lymphocytic leukemia in the era of new agents.
Eichhorst B; Hallek M
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):149-155. PubMed ID: 27913474
[TBL] [Abstract][Full Text] [Related]
9. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.
Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R
Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367
[TBL] [Abstract][Full Text] [Related]
10. Risk-Adapted Therapy in Early-Stage Chronic Lymphocytic Leukemia.
Langerbeins P; Groß-Ophoff-Müller C; Herling CD
Oncol Res Treat; 2016; 39(1-2):18-24. PubMed ID: 26891412
[TBL] [Abstract][Full Text] [Related]
11. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
Iovino L; Shadman M
Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
[TBL] [Abstract][Full Text] [Related]
12. Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia.
Yun X; Zhang Y; Wang X
Biomark Res; 2020; 8():40. PubMed ID: 32939265
[TBL] [Abstract][Full Text] [Related]
13. Use of minimal residual disease assessment in the treatment of chronic lymphocytic leukemia.
Owen C; Christofides A; Johnson N; Lawrence T; MacDonald D; Ward C
Leuk Lymphoma; 2017 Dec; 58(12):2777-2785. PubMed ID: 28509580
[TBL] [Abstract][Full Text] [Related]
14. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
15. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
Nabhan C; Raca G; Wang YL
JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
[TBL] [Abstract][Full Text] [Related]
16. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.
Molica S; Shanafelt TD; Giannarelli D; Gentile M; Mirabelli R; Cutrona G; Levato L; Di Renzo N; Di Raimondo F; Musolino C; Angrilli F; Famà A; Recchia AG; Chaffee KG; Neri A; Kay NE; Ferrarini M; Morabito F
Am J Hematol; 2016 Nov; 91(11):1090-1095. PubMed ID: 27465919
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia.
Sagatys EM; Zhang L
Cancer Control; 2012 Jan; 19(1):18-25. PubMed ID: 22143059
[TBL] [Abstract][Full Text] [Related]
18. Prognosis Assessment of Early-Stage Chronic Lymphocytic Leukemia: Are We Ready to Predict Clinical Evolution Without a Crystal Ball?
González-Gascón-Y-Marín I; Muñoz-Novas C; Figueroa I; Hernández-Sánchez M; Rodríguez-Vicente AE; Quijada-Álamo M; Pérez-Carretero C; Moreno C; Collado R; Espinet B; Puiggros A; Heras NL; Bosch F; Hernández JÁ;
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):548-555.e4. PubMed ID: 32389671
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia: prognostic factors and impact on treatment.
Parker TL; Strout MP
Discov Med; 2011 Feb; 11(57):115-23. PubMed ID: 21356166
[TBL] [Abstract][Full Text] [Related]
20. CLL biology and prognosis.
Dighiero G
Hematology Am Soc Hematol Educ Program; 2005; ():278-84. PubMed ID: 16304392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
